Stay updated on Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial
Sign up to get notified when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.

Latest updates to the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision label in the Study Documents section was updated from v3.6.2 to v3.6.3, indicating a new document revision.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page shows a new revision tag, changing from v3.6.0 to v3.6.2. This indicates a minor update to the page without altering the study details.SummaryDifference0.0%

- Check32 days agoChange DetectedNew navigation items were added (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study). The Intervention label was standardized from 'Intervention / Treatment' to 'Intervention/Treatment', the revision tag updated to v3.6.0, and a recruitment note indicates no more participants are being sought.SummaryDifference0.3%

- Check39 days agoChange DetectedThe page's revision label was updated to Revision: v3.5.5, replacing the previous v3.5.4. This reflects a small administrative update to the page rather than changes to its substantive content.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a minor update to the page’s text or formatting rather than substantive changes to the study details.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page’s UI/backend revision label was updated from version v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.